Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

NCT02833974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK2245035 Nasal Spray Solution
DRUG: Placebo Nasal Spray Solution

Sponsor

GlaxoSmithKline